Clinical Trial Update: Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Boanmycin hydrochloride in combination with docetaxel for patients with lung squamous cell carcinoma; status information is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• Boanmycin hydrochloride (boanmycin hydrochloride)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Squamous Cell Lung Cancer | Phase 2 | Status: UNKNOWN